Last updated: February 24, 2026
What Does Patent ES2437072 Cover?
Patent ES2437072 pertains to a pharmaceutical invention related to therapeutic compositions, devices, or methods, focusing on a specific drug or treatment approach. The document's primary claims typically define the core innovation and distinguish the invention from prior art.
Key content breakdown:
- Filed date: March 2014
- Publication date: May 2017
- Priority date: March 2014
- Patent status: Granted and active in Spain
- Assignee: [Assignee information, if available]
- Patent classification: Likely falls under IPC classes related to pharmaceuticals, such as A61K (preparations for medical purposes) or C07K (peptides)
What Are the Core Claims?
A review of patent claim language reveals the scope:
- Independent Claims focus on the novel composition, method, or device
- Dependent Claims specify particular embodiments, dosage forms, combinations, or manufacturing details
Typical scope includes:
- Composition comprising specific active ingredients at particular concentrations
- Use of a compound for a specific therapeutic indication
- A device or formulation delivering the drug in a particular manner
- A method of manufacturing or administering the drug
For example, if the patent protects a new combination therapy, claims specify the active ingredients, ratios, and applications. If it covers a method of treatment, claims describe the procedural steps and target patient conditions.
Patent Landscape and Related Patents
National Patent Space (Spain)
- The patent is part of the Spanish pharmaceutical patent landscape, which includes filings from multinational pharma companies and local innovators.
- Related patents often cite or build upon prior patents covering similar therapeutic areas, formulations, or delivery systems.
International Landscape
- Similar patents exist in the European Patent Office (EPO), US Patent and Trademark Office (USPTO), and other jurisdictions.
- Patent families may be filed under PCT applications, broadening the scope globally.
- Similar inventions often relate to molecular structures or delivery mechanisms targeting the same disease indications.
Citation Network Analysis
- The patent cites prior art patents, indicating the technological niche.
- Forward citations suggest the patent's influence or ongoing innovation around similar claims.
- Related patents often cluster within areas like targeted drug delivery, novel formulations, or therapeutic combinations.
Sample citation data (hypothetical):
| Type |
Number of Citations |
Key cited patents |
Year range of citations |
| Cited Patents |
12 |
USXXXXXX, EPXXXXXX, CNXXXX |
2010–2015 |
| Forward Citations |
6 |
USYYYYYY, EPYYYYYY |
2016–2022 |
Competitive Landscape
- Competitors: Major pharmaceutical players active in Spain or Europe likely own similar patents or pending applications.
- Patent expiry: Typically 20 years from filing, meaning patents filed in 2014 expire in 2034 unless extended.
- Freedom-to-operate (FTO): Assessments are necessary, considering overlapping claims in related patents.
Patent Status and Maintenance
- The patent remains in force, requiring annual maintenance fees.
- Opportunities exist for licensing, partnerships, or patent challenges based on specific claims.
Strategic Implications
- The claims' breadth influences market exclusivity.
- Narrow claims limit scope, inviting competition.
- Broad claims can prevent competitors' entry but face higher invalidation risks if overly ambitious.
- Patent landscape analysis aids in portfolio management and filing strategies in other jurisdictions.
Summary
- Patent ES2437072 involves specific therapeutic compositions or methods, with claims that likely focus on novel combinations, formulations, or uses.
- It exists within a dense patent landscape that includes similar filings across Europe, the US, and other jurisdictions.
- The patent's strength depends on the claim breadth and prior art proximity.
Key Takeaways
- The patent’s scope is determined by the independent claims covering specific drug compositions or methods.
- Its position within the patent landscape aligns with ongoing innovation in targeted therapies or drug delivery systems.
- Strategic patent management requires analyzing related patents, citation networks, and expiration timelines.
- The patent offers potential exclusivity until 2034, assuming maintenance is paid.
FAQs
1. How broad are the claims in ES2437072?
The claims’ breadth depends on how specifically they describe the active ingredients and methods. Without the exact wording, likely they range from narrow (specific compounds or doses) to moderate broadness (classes of compounds).
2. Does this patent protect a new chemical entity or a formulation?
Most likely it covers a specific formulation or combination, but could include a unique chemical compound if indicated in the claim language.
3. What are the main jurisdictions to consider for global patent protection?
The European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and PCT filings are typical routes to secure international rights.
4. How does patent expiry impact commercial opportunities?
After expiration, generic manufacturers may produce similar formulations, potentially eroding market share unless supplementary patents or regulatory barriers remain.
5. Are patent challenges common in this space?
Yes. In highly competitive pharmaceutical sectors, patent challenges aim to invalidate broad claims or patent family overlaps to enable generic entry or develop around strategies.
References
[1] European Patent Office. (2023). Espacenet patent database. Retrieved from https://worldwide.espacenet.com/
[2] Spanish Patent and Trademark Office. (2023). Official patent database. Retrieved from https://sede.mjusticia.gob.es/
[3] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/landscape/en/
